This is part of an email I got today from 23andme, my bolding:
Today, 23andMe was granted authorization by the U.S. Food and Drug Administration (FDA) to offer the Bloom syndrome carrier status report. This is an important first step in fulfilling our commitment to return genetic health reports to consumers.
This is the first time the FDA has granted authorization to offer a direct-to-consumer genetic test, and it gives us a regulatory framework for future submissions. While this authorization is for a single carrier status test only, we are committed to returning health information to our US customers who don't already have this information once more tests have been through this process and we have a more comprehensive product offering.